Andrea Alms Video: Money in Motion 157 - Disruption in the Gene Cell Therapy Market
TRANSCRIPT: Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your money in motion. In the news selling gene therapy reckoning industry giants retreat as safety concerns and regulatory shifts reshape the landscape. Vertex, Pfizer, Takeda are leaving the AAV gene medicine research. The manufacturing economics are challenging a 2 to $3 million per dose an